BIOASIS TECHNOLOGIES
Bioasis Technologies Inc. is a biopharmaceutical company developing the xB3 ™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The delivery of therapeutics across the blood brain barrier represents the final frontier in treating neurological disorders. The in-house development programs at Bioasis are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.
BIOASIS TECHNOLOGIES
Industry:
Biotechnology Pharmaceutical
Founded:
2007-01-01
Address:
Richmond, British Columbia, Canada
Country:
Canada
Website Url:
http://www.bioasis.us
Total Employee:
101+
Status:
Active
Contact:
1.203.390.7395
Email Addresses:
[email protected]
Total Funding:
8.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Burzynski Research Institute
Burzynski Research Institute (BRI) is a biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
Founder
Stock Details
Investors List
The Lind Partners
The Lind Partners investment in Post-IPO Debt - Bioasis Technologies
Official Site Inspections
http://www.bioasis.us Semrush global rank: 5.62 M Semrush visits lastest month: 1.5 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Bioasis Technologies"
Bioasis Technologies Inc. - BioCT
Bioasis Technologies is a biopharmaceutical company founded in 2007 and with offices in Canada and the U.S. The company is focused on overcoming the limitations of therapeutic …See details»
Bioasis Technologies - Crunchbase Company Profile
Bioasis Technologies Inc. is a biopharmaceutical company developing the xB3 ™ platform, a proprietary technology for the delivery of therapeutics across the …See details»
Bioasis Technologies Inc. (BIOAF) - Yahoo Finance
See the company profile for Bioasis Technologies Inc. (BIOAF) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Bioasis Provides Corporate Update and Announces Suspension of …
Jun 20, 2023 Bioasis Technologies Inc. NEW HAVEN, Conn., June 20, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the …See details»
Bioasis Announces AGM Results and Provides Update on Financial …
Feb 3, 2023 As disclosed on January 23, 2023, following Bioasis’ termination of the arrangement agreement between Bioasis and Midatech Pharma plc (“Midatech”), Bioasis was entitled to …See details»
Bioasis Technologies - Overview, News & Similar companies
View Bioasis Technologies (www.bioasis.us) location in Connecticut, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Bioasis Technologies
Dec 18, 2024 Bioasis Technologies Inc. was incorporated in 2006 and is headquartered in New Haven, Connecticut. History Bioasis Technologies Inc. was founded in 2006 by Dr. Brad …See details»
Bioasis Technologies Company Profile: Overview and Full News …
Bioasis Technologies Inc. (OTC: BIOAF) is advancing several candidates in its pipeline, including one in the IND-enabling phase that we expect to enter the clinic by the end of next year . The …See details»
Bioasis Technologies Inc. - Facebook
Bioasis Technologies Inc. 4,150 likes. Delivering effective brain therapies for rare and orphan diseases. TSXV: BTI | OTCQB: BIOAFSee details»
Bioasis Technologies - Craft
Oct 29, 2024 Bioasis Technologies is a biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of neurological diseases. It …See details»
Bioasis Technologies' approach seeks a …
Oct 21, 2021 The World Health Organization estimates that neurological disorders cause 12 per cent of the world’s deaths; Scientists are beginning to understand the extraordinary …See details»
Bioasis Provides Corporate Update and Announces Suspension of ...
Jun 20, 2023 About Bioasis. Bioasis is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor and the xB 3 …See details»
Bioasis Technologies Inc. (BIOAF) - Yahoo Finance Canada
The company also has a research collaboration and license agreement with Neuramedy Co Ltd. to research, develop, and commercialize an xB3TM version of its antibody, Tomaralimab. …See details»
How Bioasis Technologies is transforming neurological treatment
Apr 7, 2021 Tech partnerships and secured funding are maximizing Bioasis’ research potential In addition to the company’s potential applications of XB 3 -001 in breast and gastric cancers, …See details»
Bioasis Technologies Inc. and Aposense Enter into a
Mar 31, 2021 [email protected] +1 203 533 7082. Follow on: Facebook Instagram LinkedIn Twitter. BTI-CRP. About Bioasis. Bioasis Technologies Inc. is a biopharmaceutical company …See details»
Bioasis and Chiesi Group Announce Rare Diseases Strategic Alliance
Its R&D organization is headquartered in Parma (Italy), and is integrated with R&D groups in France, the USA, the UK and Sweden to advance Chiesi's pre-clinical, clinical and registration …See details»
biOasis Technologies, Inc. (biOasis Technologies, Inc.) - 药物管线_ …
Bioasis Loans On 19 December 2022 the Company entered into a Promissory Note and Security Agreement with Bioasis to assist in the short term with Bioasis’ working capital requirements. …See details»
Bioasis Technologies Inc. Mails Management Information Circular …
Jan 11, 2023 Bioasis Technologies Inc. NEW HAVEN, Conn., Jan. 11, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the …See details»
Bioasis Technologies - FlashFunders
Nov 10, 2019 Bioasis is opening the door to delivery of biologic therapeutics to the brain for CNS diseases ... Dr. Clairmont helped to establish the Connecticut chapter for the Association for …See details»
U.S. Mission to the Organization of American States Launches New ...
Dec 13, 2024 The United States Mission to the Organization of American States (OAS) is pleased to announce its partnership with the OAS Executive Secretariat for Integral …See details»